Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
07/2010
07/08/2010WO2010078466A2 Sand fly salivary proteins with anti-complement activity and methods of their use
07/08/2010WO2010078324A2 Companion animal compositions including lipoic acid and methods of use thereof
07/08/2010WO2010078322A1 Use of lipoic acid for treating or preventing degenerative joint conditions, osteoarthritis, cartilage damage, and related disorders in companion animals
07/08/2010WO2010077686A1 Isoindolinone and related analogs as sirtuin modulators
07/08/2010WO2010076813A1 Thienopyridines as pharmacologically active agents
07/08/2010WO2010048559A3 Phenylpyrazole inhibitors of store operated calcium release
07/08/2010WO2010039742A3 Methods to reduce b-helper t cells to treat autoimmune diseases
07/08/2010WO2010034011A3 Phenylthiophenyldihydrobenzothiazepine inhibitors of store operated calcium release
07/08/2010WO2010028254A3 Substituted quinazoline inhibitors of growth factor receptor tyrosine kinases
07/08/2010US20100174076 Coumarin derivatives useful as tnf alpha inhibitors
07/08/2010US20100173942 Phosphodiesterase 4 inhibitors
07/08/2010US20100173916 Xanthine Derivatives, the Preparation Thereof and Their Use as Pharmaceutical Compositions
07/08/2010US20100173901 Substituted Heterocyclic Compounds
07/08/2010US20100173896 Organic Compounds
07/08/2010US20100173878 Organic compounds
07/08/2010US20100173870 Phosphonate Compounds
07/08/2010US20100173867 Injectable cross-linked polymeric preparations and uses thereof
07/08/2010US20100173848 Methods of inhibiting chemokine binding to chemokines receptors
07/08/2010US20100173838 Novel process for the preparation of cyclosporin derivatives
07/08/2010US20100173413 Pyridine compounds
07/08/2010US20100173010 Polymetaphosphate based formulations for therapy of microcrystalline arthropathies
07/08/2010US20100173009 Silicate-substituted hydroxyapatite
07/08/2010US20100173008 Method of treating or alleviating the symptoms of alesion in mammal
07/08/2010US20100173002 Microcapsules with improved shells
07/08/2010US20100172993 Particles for delivery of active ingredients, process of making and compositions thereof
07/08/2010US20100172992 Pathogenic attenuation via the administration of an equilibiotic compound
07/08/2010US20100172983 Pharmaceutical Compositions for the Coordinated Delivery of Naproxen and Esomeprazole
07/08/2010US20100172971 Compositions for Inhibiting NADPH Oxidase Activity
07/08/2010US20100172966 Methods and compositions for cellular reprogramming
07/08/2010US20100172954 Irradiated implantable bone material
07/08/2010US20100172953 Biopolymer Based Implantable Degradable Devices
07/08/2010US20100172952 Electrospun Scaffolds And Methods Of Generating And Using Same
07/08/2010US20100172949 Consensus peptide
07/08/2010US20100172912 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies
07/08/2010US20100172904 Mcp1 fusions
07/08/2010US20100172829 Enhanced carriers for the delivery of microparticles to bodily tissues and fluids
07/08/2010CA2750140A1 Methods of treating or preventing degenerative joint conditions, osteoarthristis, cartilage damage, and related disorders in companion animals
07/08/2010CA2748982A1 Thienopyridines as pharmacologically active agents
07/08/2010CA2746221A1 Isoindolinone and related analogs as sirtuin modulators
07/08/2010CA2746139A1 Companion animal compositions including lipoic acid and methods of use thereof
07/07/2010EP2204192A1 Prophylactic or therapeutic agent for inflammatory disease comprising thymidine phosphorylase inhibitor as active ingredient
07/07/2010EP2204181A2 Protease inhibitors
07/07/2010EP2203446A1 Chromenone derivatives and their use for leukotriene biosynthesis inhibition
07/07/2010EP2203057A1 Method and compositions for treatment or prevention of inflammatory conditions
07/07/2010EP2040674B1 Cationic liposomal preparations for the treatment of rheumatoid arthritis
07/07/2010EP1491537B1 Hydroxymorpholinone derivative and medicinal use thereof
07/07/2010EP1485099B1 Inhibitors of histone deacetylase
07/07/2010EP1455601B1 Composition for promotion of bone growth and maintenance of bone health
07/07/2010EP1383919B1 Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor
07/07/2010EP1274834B1 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS
07/07/2010CN1859918B Use of hyaluronic acid for treating acute and overuse sprain and strain
07/07/2010CN101772497A New crystalline forms of 2 -hydroxy- 3- [5- (morpholin- 4- ylmethyl) pyridin-2-yl] ih- indole- 5 -carbonitrile citrate
07/07/2010CN101772351A A novel bone mass increasing agent
07/07/2010CN101768152A Piperidine derivatives useful as CCR5 antagonists
07/07/2010CN101768150A 2-[3-cyano-4-isobutoxy phenyl]-4-methylthiazol-5-formic acid crystal forms and preparation method thereof
07/07/2010CN101768136A New crystal form of febuxostat and preparation method thereof
07/07/2010CN101766809A Method and device for multiplying and differentiating cells in the presence of growth factors and of a biological matrix or of a supporting structure
07/07/2010CN101766775A Medicine for treating lumbar disc herniation and osteoproliferation
07/07/2010CN101766773A Chinese medicine prescription for treating talagia
07/07/2010CN101766750A Chinese medicine conditioning powder for bathing
07/07/2010CN101766746A External bee venom liniment
07/07/2010CN101766729A Damp-clearing pain-relieving liquor and acupoint application treatment method
07/07/2010CN101766724A Chinese medicine preparation for treating traumatic injury and rheumatic pain and preparation method thereof
07/07/2010CN101766723A Chinese medicine preparation for treating traumatic injury and rheumatic pain and preparation method thereof
07/07/2010CN101766709A Pharmaceutical composite for osteoporosis treatment and preparation method thereof
07/07/2010CN101766688A Medicinal footbath liquor
07/07/2010CN101766675A Preparation method of silktree albizia bark extract for inhibiting angiogenesis and application
07/07/2010CN101766669A Chinese medicament for treating injuries from falls
07/07/2010CN101766663A Chinese medicine preparation for external use for rheumatoid arthritis treatment
07/07/2010CN101766627A Compound allopurinol dispersible tablet
07/07/2010CN101057925B Preparation technology for 'jieguqili' capsule
07/06/2010US7749986 Homogeneously formulating microdosed active principles
07/06/2010US7749964 treating osteoarthritis with OSTEOCHONDRAL GRAFTS consisting of ACTIVE GROWTH FACTORBONE MORPHOGENETIC PROTEIN
07/06/2010US7749960 An enteral composition or a pharmaceutical containing osteoprotegerin obtained from human or bovine milk or colostrum; preventing or treating disorders associated with bone metabolism and immune function
07/06/2010US7749954 Use of calcitonin in osteoarthritis
07/06/2010US7749752 Using vector comprisng nucleotide sequences coding cell binding elements to transform cells and identify lymphocyte response modulators
07/06/2010US7749735 Interferon receptor variant for treatment and prevention of cell proliferative, autoimmune and viral diseases; prolonged activation of interferon beta
07/06/2010US7749718 Method for raising or isolating an antibody to DCRS5
07/06/2010US7749543 Methods useful in the treatment of bone resorption diseases
07/06/2010US7749500 Antibodies to IL-17 polypeptides and therapeutic uses thereof
07/06/2010CA2454863C Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
07/06/2010CA2446149C Vitamin d analogues
07/06/2010CA2437109C Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity
07/06/2010CA2393883C Salicylamide derivatives
07/06/2010CA2382129C Novel derivatives of flavones, xanthones and coumarins
07/06/2010CA2370814C Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit
07/01/2010WO2010075423A2 Dendrimer based modular platforms
07/01/2010WO2010075287A2 Compounds and methods for the treatment of pain and other diseases
07/01/2010WO2010075263A2 Compounds and methods for enhancing erythropoiesis
07/01/2010WO2010075086A2 Pyrrolidinone inhibitors of pde-4
07/01/2010WO2010074284A1 Pyrazolopyrimidine compound
07/01/2010WO2010074193A1 Novel bicyclic heterocyclic compound
07/01/2010WO2010074089A1 Indanyl compounds
07/01/2010WO2010074088A1 Cyclic amine compounds
07/01/2010WO2010072797A1 Compounds and methods for the treatment of autoimmune and inflammatory disease
07/01/2010WO2010072774A2 Agent for treating stenosis of the spinal canal
07/01/2010WO2010072684A1 Norrin in the treatment of diseases associated with an increased tgf-beta activity
07/01/2010WO2010072607A1 Dihydropyridone amides as p2x7 modulators
07/01/2010WO2010072599A1 Dihydropyridone ureas as p2x7 modulators
07/01/2010WO2010071924A1 Osteoarthritis treatment
1 ... 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 ... 820